Fairfield Financial Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-63
Closed -$5.74K 93
2024
Q4
$5.74K Hold
63
﹤0.01% 222
2024
Q3
$6.52K Hold
63
﹤0.01% 238
2024
Q2
$6.07K Buy
+63
New +$5.81K ﹤0.01% 234
2023
Q4
$4.93K Buy
62
+1
+2% +$75 ﹤0.01% 271
2023
Q3
$4.37K Hold
61
﹤0.01% 260
2023
Q2
$4.7K Hold
61
﹤0.01% 274
2023
Q1
$4.57K Buy
61
+1
+2% +$74 ﹤0.01% 273
2022
Q4
$4.75K Hold
60
﹤0.01% 255
2022
Q3
$4.21K Hold
60
﹤0.01% 264
2022
Q2
$4.78K Buy
60
+1
+2% +$78 ﹤0.01% 245
2022
Q1
$4.49K Buy
+59
New +$4.67K ﹤0.01% 261

Other funds holding CL

Fairfield Financial Advisors's CL Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 63 shares — an estimated $5.74K sold.

Fairfield Financial Advisors first reported a position in CL in Q1 2022 and held it in 11 quarters. The position peaked at $6.52K in Q3 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 63 Colgate-Palmolive shares in Q1 2025, an estimated $5.74K.
  • Fairfield Financial Advisors first reported a position in Colgate-Palmolive in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's Colgate-Palmolive position peaked at $6.52K in Q3 2024.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.